Difference between revisions of "Part:BBa K4165080"

(Functional Parameters)
(PDB Structure)
Line 16: Line 16:
 
===Dry-Lab Charachtarizstion===
 
===Dry-Lab Charachtarizstion===
  
===PDB Structure===
+
===Modelling===
It has both NMR structure and a predicted model (AlphaFold).
+
 
+
 
+
NMR structure:
+
https://www.rcsb.org/structure/2LEO
+
Molprobity:
+
Clash Score:
+
Ramachandran Favoured:
+
Ramachandran Outliers:
+
Rotamers Outliers:
+
C-beta Deviations:
+
Q-Mean:
+
 
+
  
 
<html>
 
<html>
Line 36: Line 23:
  
 
                   Figure 1.: A graphical illustration showing the Inhibitor (NMR).
 
                   Figure 1.: A graphical illustration showing the Inhibitor (NMR).
 
 
 
AlphaFold:
 
https://alphafold.ebi.ac.uk/entry/P58062
 
Molprobity:
 
Clash Score:
 
Ramachandran Favoured:
 
Ramachandran Outliers:
 
Rotamers Outliers:
 
C-beta Deviations:
 
Q-Mean:
 
 
 
 
<html>
 
<p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/switches/p85062-alphafold.png" style="margin-left:200px;" alt="" width="500" /></p>
 
</html>
 
 
                  Figure 1.: A graphical illustration showing the Inhibitor (AlphaFold).
 
 
 
  
 
===References===
 
===References===

Revision as of 00:40, 12 October 2022


SPINK7 (Serine Peptidase Inhibitor Kazal type 7).

This basic part encodes Human serine protease inhibitor known as SPINK7 which is able to inhibit trypsin-like proteases, like HtrA1 (BBa_K4165004).


Usage and Biology

This type of family encodes for a type of inhibitor that is able to inhibit serine proteases. The inhibitor binds to trypsin proteases and since the catalytic core of HtrA1 (BBa_K4165004) is considered as a tyrpsin-like catalytic domain, so this inhibitor also is considered to inhibit the function of HtrA1 [1] - [4].

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Dry-Lab Charachtarizstion

Modelling

                 Figure 1.: A graphical illustration showing the Inhibitor (NMR).

References

1 - Frochaux, V., Hildebrand, D., Talke, A., Linscheid, M. W., & Schlüter, H. (2014). Alpha-1-antitrypsin: a novel human high temperature requirement protease A1 (HTRA1) substrate in human placental tissue. PloS one, 9(10), e109483.
2 - Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., ... & Ehrmann, M. (2005). Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proceedings of the National Academy of Sciences, 102(17), 6021-6026.
3 - Eigenbrot, C., Ultsch, M., Lipari, M. T., Moran, P., Lin, S. J., Ganesan, R., ... & Kirchhofer, D. (2012). Structural and functional analysis of HtrA1 and its subdomains. Structure, 20(6), 1040-1050.
4 - Chen, T. J., Tian, Y. F., Chou, C. L., Chan, T. C., He, H. L., Li, W. S., ... & Lai, H. Y. (2021). High spink4 expression predicts poor outcomes among rectal cancer patients receiving CCRT. Current Oncology, 28(4), 2373-2384.